HomeMy WebLinkAboutAgreement A-15-323-2 with CSUF Foundation.pdf
COUNTY OF FRESNO
Fresno, CA
-1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
AMENDMENT II TO AGREEMENT
THIS AMENDMENT, hereinafter referred to as “Amendment II”, is made and entered into this
____ day of __________, 2017, by and between the COUNTY OF FRESNO, a Political Subdivision
of the State of California, hereinafter referred to as “COUNTY”, and CALIFORNIA STATE
UNIVERSITY, FRESNO FOUNDATION, a Private Non-Profit Organization, whose address is
4910 N. Chestnut Avenue, Fresno, California, 93726-1952, hereinafter referred to as
“CONTRACTOR” (collectively the “parties”).
WHEREAS the parties entered into that certain Agreement, identified as COUNTY Agreement
No. A-15-323, effective July 14, 2015, and Amendment I to Agreement No. A-15-323, effective July
14, 2015, hereinafter collectively referred to as “Agreement”, whereby CONTRACTOR agreed to
provide certain program evaluation services to COUNTY’s Department of Public Health; and
WHEREAS the parties now desire to amend the Agreement regarding changes as stated below
and restate the Agreement in its entirety.
NOW, THEREFORE, in consideration of their mutual promises, covenants and conditions,
hereinafter set forth, the sufficiency of which is hereby acknowledged, the parties agree as follows:
1. That the following be deleted from existing COUNTY Agreement No. A-15-323, Page
2, beginning with Line 4:
“This Agreement shall automatically be extended for one (1) additional twelve (12)
month period upon the same terms and conditions herein set forth, unless written notice of nonrenewal
is given by either CONTRACTOR or COUNTY or COUNTY’s DPH Director, or designee, not later
than sixty (60) days prior to the close of the current Agreement term.”
2. That the existing COUNTY Agreement No. A-15-323, Page 3, beginning with Section
4, “COMPENSATION,” Line 6, with the word “In” and ending on Line 8, with the word
“Agreement” be deleted and the following inserted in its place:
“In no event shall actual services performed under this Agreement be in excess of One
Hundred Seventy-Five Thousand, One Hundred Twenty-One and No/100 Dollars ($175,121) during
the period July 14, 2015 through September 30, 2016, and Eighty-Three Thousand, Five Hundred and
No/100 Dollars ($83,500) during the period of October 1, 2016 through September 29, 2017.”
COUNTY OF FRESNO
Fresno, CA
-2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
3. That all references in existing COUNTY Agreement No. A-15-323 to “Exhibit A” shall
be changed to read “Revised Exhibit A”, attached hereto and incorporated herein by reference.
4. That all references in existing COUNTY Agreement No. A-15-323 to “Revised Exhibit
B” shall be changed to read “Revised Exhibit B-1”, attached hereto and incorporated herein by
reference.
5. Except as otherwise provided in this Amendment II, all other provisions of the
Agreement remain unchanged and in full force and effect. This Amendment II shall become effective
upon execution.
6. COUNTY and CONTRACTOR agree that this Amendment II is sufficient to amend the
Agreement, and that upon execution of this Amendment II, the Agreement, Amendment I, and
Amendment II together shall be considered the Agreement.
///
///
///
///
///
///
///
///
///
///
///
///
///
///
///
///
///
Comprehensive Evaluation and Actual Use Assessment Plan
Awardee Name:
Awardee Type:
Fresno County Department of Public Health
PICH
Date Printed:7/10/2016
Plan Name Farm to Table
This plan measures actual use
This is a required outcome evaluation of an innovative intervention
This is a voluntary evaluation
What is the purpose of this plan?
Is this evaluation/assessment focused on a single intervention or a broader strategy (group of interventions
aiming to achieve similar outcomes)?
Single Intervention
Strategy (group of interventions)
Overview
John A. Capitman, PhD
Executive Director, Central Valley Health Policy Institute
California State Univeristy, Fresno
559‐228‐2157
jcapitman@csufresno.edu
List any topics you would like to see addressed through evaluation TA, webinars, collaborative calls or other training
opportunities.
Nam
Title
Affiliation
Phone
Emai
Who is the primary point of contact for this evaluation plan?
Sunday, July 10, 2016 Page 1 of 56
Revised Exhibit A
Plan Name Farm to Table
Farm to TableIntervention/strategy name
Risk factor(s)/focus areas
Description The Fresno County Department of Public Health (FCDPH) and the Farm
to Table Workgroup will increase access to fruits and vegetables in
communities with the greatest health disparities by collaborating with
local food aggregators, school districts, and community agencies for
126,347 residents. Two models will be implemented during the
intervention, 1) Food Recovery and 2) a modified community
supported agriculture (CSA) model. Fresno Metro Ministry will
implement a Food Recovery model where they distribute food at well
developed community resource locations such as churches, community
centers, and parks. Food Commons Fresno will use school sites to sell
food boxes adapting the CSA model. This evaluation is of actual use;
therefore, the plan is designed to measure actual use of the CSA model
food distribution at the school sites. This will be done by collecting all
receipts from each purchase that is made. This will allow the Evaluation
Team to determine the extent to which community members actually
use the site. The Food Recovery sites will be evaluated for their ability
to distribute pounds of food to local communities and their ability to
create access points for communities of high need.
This intervention meets CDC's criteria for
innovative.
Explain
No
Yes
Anticipated start date of intervention(month/year)4/1/2015
Anticipated end date of intervention(month/year)9/30/2017
Does intervention/strategy aim to reduce health
disparities?
The intervention focuses on a general population
only (typically jurisdiction wide)
The intervention aims to reduce health disparities by focusing on
both a general population(jurisdiction wide) and one or more
specific sub‐populations
The intervention aims to reduce health disparities by focusing on
one or more specific sub‐populations
Intervention Description
Please include a logic model for the intervention as an attachment when you submit your evaluation plan to CDC.
Tobacco
Nutrition
Physical Activity
Community and Clinical Linkages
Communication
Sunday, July 10, 2016 Page 2 of 56
Revised Exhibit A
Plan Name Farm to Table
Please list each of your evaluation questions. Evaluation questions should relate to the impact of an intervention/strategy on
specific health behaviors and/or health outcomes. Research questions are not appropriate. If this plan is to meet the actual
use assessment requirement, then at least one question should be related to actual use. In addition, all questions should
inform the evidence base and/or contribute to program improvement.
Evaluation Questions
Evaluation Question What indicators will be measured to
address this question?
Describe how this question will contribute to the evidence
base, program improvement, or an assessment of actual use.
This question will measure the programs ability to reach
communities with low access to fruits and vegetables.
Answering this question will provide insight to the number
of access points provided to community members to attain
fresh fruits and vegetables. This question will also help to
estimate the number of individuals who are in close
proximity to the access point.
To what extent does
the Farm to Table CSA
intervention increase
access to fruits and
vegetables in low
income
neighborhoods in the
City of Fresno that
currently have limited
access?
The number of sites created by FCDPH.
This question will measure the number of individuals that
have increased access to fresh fruits and vegetables.
In neighborhoods that
incorporate a food
recovery or
community supported
agriculture model, to
what extent does
FCDPH increase the
number of individuals
with increased access
to fresh healthy
foods?
The number of individuals who
purchase or receive fresh fruits and
vegetables from Community Supported
Agriculture or food recovery.
The number of individuals with
Supplemental Nutrition Assistance
Program who purchase fresh fruits and
vegetables from Community Supported
Agriculture or receive food from food
recovery.
Sunday, July 10, 2016 Page 3 of 56
Revised Exhibit A
Plan Name Farm to Table
Evaluation Design
Please describe the overall evaluation design, including the number and description of any comparison groups (if applicable)
and the timing and frequency of data collection (e.g., before and after implementation).
The proposed evaluation will use a cross‐sectional design in order to estimate the number of community members with
improved access to healthy food options. This evaluation will include an assessment of actual use by collecting purchase
receipts and counting the number of individuals that purchase fresh fruits and vegetables. The Evaluation Team will work
closely with Food Commons Fresno and Fresno Metro Ministry in order to track all individuals who either purchase food or
pick‐up food at the access points. When evaluating Food Commons Fresno at the school sites, a report of all transactions
made will be collected and analyzed by the Evaluation Team. These records will be reviewed to determine the number of
access points created throughout program implementation, the number of individuals who make purchases, and the number
of individuals who purchase food using Supplemental Nutrition Assistance Program benefits. Data will be collected monthly
and records will be attained for all purchases made. Individuals will be tracked throughout the program. In order to evaluate
the Food Recovery project incorporated by Fresno Metro Ministry, the Evaluation Team will work closely to track the pounds
of food distributed to each access point. A general estimation of the number of individuals impacted by the redistribution of
recovered food will be made.
Sunday, July 10, 2016 Page 4 of 56
Revised Exhibit A
Plan Name Farm to Table
Instruments
Please list each of your evaluation instruments/data sources. If you know the indicators you want to measure, but have not
yet selected the instruments, indicate "TBD" for the instrument. Please include available instruments as attachments when
you submit your evaluation plan to CDC.
Instrument/
Data Source
Reference Please describe any modifications
made to the original instrument
What key indicators are measured by this
instrument/data source?
The primary tool
will be receipts
collected from all
the purchases
made at each site.
These receipts will
be used to
compare who used
SNAP services to
purchase food.
United States
Department of
Agriculture Food and
Nutrition Service
hƩp://www.fns.usda.
gov/farmtoschool/pro
curing‐local‐
foodsprovides
extensive guidelines
on tool/instrument
developmnet. An
evaluation can be
made by tracking
farm origins on
distributor invoices.
Define ‘Local’: a
boundary must be
established
N/A The number of individuals who purchase
or receive fresh fruits and vegetables
from Community Supported Agriculture
or food recovery.
The number of individuals with
Supplemental Nutrition Assistance
Program who purchase fresh fruits and
vegetables from Community Supported
Agriculture or receive food from food
recovery.
The number of sites created by FCDPH.
Instrument/
Data Source
Reference Please describe any modifications
made to the original instrument
What key indicators are measured by this
instrument/data source?
Survey Oakland, CA Fresh
Food Share project.
Questions were adapted from
Oakland's implementation of a Fresh
Food Share project.
The number of individuals who purchase
or receive fresh fruits and vegetables
from Community Supported Agriculture
or food recovery.
Sunday, July 10, 2016 Page 5 of 56
Revised Exhibit A
Plan Name Farm to Table
Sampling Plan
The primary tool will be receipts collected from all the purchases
made at each site. These receipts will be used to compare who
used SNAP services to purchase food.
Instrument Name
DescriptionSub‐population
Are you trying to represent any specific subpopulations in your sample? If yes, please complete this table by checking the
subpopulation included in your sample, indicating the desired sample size per group, and describing in the space provided.
Sampling Plan
Intended Sample Size
A random sample of the community supported agriculture sites will be observed so that we can develop an unbiased
estimate of how many individuals use the resource. By using a random sampling strategy, we can estimate with the highest
the number of individuals who benefit from the CSA sites. The CSA site will be the only level of sampling included in this
evaluation. At each observation, during the randomly allotted time period, all individuals who purchase a food box will be
counted.
Please provide your reasoning and/or justification for the sampling appoach. Address all levels of the sampling plan.
A limitaƟon in our sampling plan is that we are limited to the number of sites that we will make observaƟons. Another
limitation is that the random observation dates could be bias. These limitations are expected, and have been implemented
in previous evaluations.
Yes No (why not?)Not applicable
Describe the limitations of the sampling plan.
Did you conduct a power analysis?
NoYesIf yes, is your intended sample size sufficiently powered? Please explain.
# Level
Number of
Units
Intended
Sample Size Sampling Approach
1 Community Supported
Agriculture sites
9 9 universal
All CSA sites will be included in order to count the number of community participants which make a purchase from the site.
2
Sunday, July 10, 2016 Page 6 of 56
Revised Exhibit A
Plan Name Farm to Table
Age
Homeless/transient
Immigrants/Non‐native English speakers
LGBTQ
Low SES/income
People w/disabilities (cognitive or Physical)
People w/mental illness/substance abuse conditions
Race Ethnicity
Uninsured/underinsured
Other disparate subpopulation
Gender
Geography (urban, rural or frontier)
How will you recruit and/or select participants to respond to this instruments?
Will you use participation incentives to promote response rate to the instrument?
All participants who purchase food will be included.
Yes (please describe)
No
Sunday, July 10, 2016 Page 7 of 56
Revised Exhibit A
Plan Name Farm to Table
SurveyInstrument Name
Age
Homeless/transient
Immigrants/Non‐native English speakers
LGBTQ
Low SES/income
People w/disabilities (cognitive or Physical)
People w/mental illness/substance abuse conditions
Race Ethnicity
Uninsured/underinsured
Other disparate subpopulation
Gender
Geography (urban, rural or frontier)
DescriptionSub‐population
Are you trying to represent any specific subpopulations in your sample? If yes, please complete this table by checking the
subpopulation included in your sample, indicating the desired sample size per group, and describing in the space provided.
How will you recruit and/or select participants to respond to this instruments?
Will you use participation incentives to promote response rate to the instrument?
All consumers who pick‐up a food box will have the opportunity to participate in the survey. Consumers will self‐select by
their willingness to participate in the evaluation.
Yes (please describe)A $10 gift card will be given to the participant upon completion of the survey.
No
Sampling Plan
Intended Sample Size
A minimum of 20 indivdiuals are needed in order to open a school site by Food Commons Fresno. We anticipate that by
sampling at least 20 consumers per site we will have a good estimate of how many family members are benefiting from all
purchases being made.
Please provide your reasoning and/or justification for the sampling appoach. Address all levels of the sampling plan.
A limitation of the sampling process is that we will not be able to infer any findings generated from the report to the overall
population because sampling is not random.
Yes No (why not?)Not applicable
Describe the limitations of the sampling plan.
Did you conduct a power analysis?
NoYesIf yes, is your intended sample size sufficiently powered? Please explain.
# Level
Number of
Units
Intended
Sample Size Sampling Approach
1 Consumers 250 180 convenience
At each school site 20 individuals will be surveyed. All consumers who pick‐up a food box will have the opportunity to
particpate in the survey.
Sunday, July 10, 2016 Page 8 of 56
Revised Exhibit A
Plan Name Farm to Table
Data Collection Plan
Instrument Name The primary tool will be receipts collected from all the purchases made at each
site. These receipts will be used to compare who used SNAP services to
purchase food.
Please describe in detail the data collection protocol for
this instrument.
Data will be collected from receipts. The receipts will detail if
the purchase was made with SNAP benefits. The subcontractor
that is selling the food boxes will share receipts with the
evaluator.
Who will administer this instrument/collect the data?The subcontractor that is selling the food boxes will share
receipts with the evaluator.
How will you train data collectors to ensure data are
collected accurately and reliably?
Accuracy and reliablity of data collection will rely solely on
receipts. If necessary, research assistants will be trained on
data‐entry in order to separate individuals who paid with SNAP
services.
Will you collect data from the same individuals over time
(longitudinal) or from independent samples at each time
point (cross‐sectional)?
Longitudinal Cross‐sectional
Observation
Survey
Intercept survey
Interview
Records review
Please select the data collection method.
1 time
2 times
3 or more times
timing is continuous or ongoing
How many times will you administer this instrument?
Please describe the timing for when you will collect data.For the three year duration of this study, CVHPI will receipts
from the CSA sites created throughout the intervention by the
FCDPH. All sites created will be included in this analysis. At the
end of each year, a progress report will be supplied for
documentation.
Instrument Name Survey
Observation
Survey
Intercept survey
Interview
Records review
Please select the data collection method.
1 time
2 times
3 or more times
timing is continuous or ongoing
How many times will you administer this instrument?
Please describe the timing for when you will collect data.This survey will be administered at each site once. The survey
will be administered on the third week of site operation. We
anticipate that by the third week of operation the site will have
Sunday, July 10, 2016 Page 9 of 56
Revised Exhibit A
Plan Name Farm to Table
Please describe in detail the data collection protocol for
this instrument.
Trained research assistants will administer the survey. A mock
interview will be conducted in order to train the research
assistants. The research assistant will intercept the consumer
after a food pick‐up has been made. At this time, the research
assistant will assist the consumer in completing the survey.
Who will administer this instrument/collect the data?A trained research assistant will administer the survey.
How will you train data collectors to ensure data are
collected accurately and reliably?
The Evaluation Team will instruct Research Assistants through a
mock trial. This help ensure accurate and reliable
administration of the tool.
Will you collect data from the same individuals over time
(longitudinal) or from independent samples at each time
point (cross‐sectional)?
Longitudinal Cross‐sectional
a consistent base population.
Sunday, July 10, 2016 Page 10 of 56
Revised Exhibit A
Plan Name Farm to Table
Complete a data analysis plan for each question.
Data Analysis Plan
To what extent does the Farm to Table CSA intervention increase access to
fruits and vegetables in low income neighborhoods in the City of Fresno
that currently have limited access?
Evaluation Question
What indicators will be examined?
The number of sites created by FCDPH.
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
The number of sites created by the FCDP will be recorded. This variable
will be treated as a ratio value.
N/A
What procedures will you conduct to test
your assumptions?
N/A
What types of variables will be examined?
What descriptive analyses will you perform?
In neighborhoods that incorporate a food recovery or community
supported agriculture model, to what extent does FCDPH increase the
number of individuals with increased access to fresh healthy foods?
Evaluation Question
What indicators will be examined?
The number of individuals with Supplemental Nutrition Assistance Program
who purchase fresh fruits and vegetables from Community Supported
Agriculture or receive food from food recovery.
The number of individuals who purchase or receive fresh fruits and
vegetables from Community Supported Agriculture or food recovery.
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
The number of individuals who purchase or receive food from the
community site will be tallied and treated as a ratio variable. This measure
will provide information on the extent to which individuals in the
community actually use the site.
N/A
What procedures will you conduct to test
your assumptions?
N/A
What types of variables will be examined?
What descriptive analyses will you perform?
Sunday, July 10, 2016 Page 11 of 56
Revised Exhibit A
Plan Name Farm to Table
Dissemination Plan
Fresno County Health Improvement Partnership members, Fresno Food Service
and Risk Management, Community members, CDC and Peer reviewed journals.
All findings will be written and shared primarily with the Fresno Community
Health Improvement Partnership, community as well as conferences, social
media platforms, a variety of academic settings, and potentially through a peer‐
reviewed journal such as Nutrition Education and Behavior, Preventive
Medicine, Health Education and Behavior, The Journal of Child Nutrition and
Management, and Health Psychology. The findings generated by this voluntary
assessment may be utilized by stakeholders in creating a platform to present
evidence to community leaders and policy makers for positive changes to the
current food distribution practices experienced by Fresno County schools.
CVHPI will work in conjunction with FCDPH for all dissemination purposes.
List all audiences for the evaluation findings
How will you disseminate the findings from
this evaluation?
Do you plan to develop a peer ‐ reviewed
manuscript based on this evaluation?
Yes
No
Sunday, July 10, 2016 Page 12 of 56
Revised Exhibit A
Plan Name Farm to Table
For each milestone, please indicate the current status and anticipated or actual dates of initiation and completion. Also
indicate the specific activities that must be completed to achieve each milestone.
Evaluation Work Plan
Finalize evaluation plan
Evaluation Milestone Milestone Status Milestone Init Date
4/1/2015
Milestone Completion Dat
9/1/2015Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Obtain IRB approval / exemption
Evaluation Milestone Milestone Status Milestone Init Date
4/1/2015
Milestone Completion Dat
9/18/2015Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect baseline data
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze baseline data
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 13 of 56
Revised Exhibit A
Plan Name Farm to Table
Disseminate baseline data
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 14 of 56
Revised Exhibit A
Plan Name Farm to Table
Collect followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 15 of 56
Revised Exhibit A
Plan Name Farm to Table
Analyze followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 16 of 56
Revised Exhibit A
Plan Name Prescription for Health
This plan measures actual use
This is a required outcome evaluation of an innovative intervention
This is a voluntary evaluation
What is the purpose of this plan?
Is this evaluation/assessment focused on a single intervention or a broader strategy (group of interventions
aiming to achieve similar outcomes)?
Single Intervention
Strategy (group of interventions)
Overview
John Capitman, PhD
Executive Director, Central Valley Health Policay Institute
California State University, Fresno
559‐228‐2157
jcapitman@csufresno.edu
List any topics you would like to see addressed through evaluation TA, webinars, collaborative calls or other training
opportunities.
Nam
Title
Affiliation
Phone
Emai
Who is the primary point of contact for this evaluation plan?
Sunday, July 10, 2016 Page 17 of 56
Revised Exhibit A
Plan Name Prescription for Health
Prescription for HealthIntervention/strategy name
Risk factor(s)/focus areas
Description The “Rx for Health” referral system will use local resources to integrate
and promote lifestyle intervention programs (CDSMP, DASH Diet,
National Diabetes Prevention Program, and smoking cessation
programs) in federally qualified health centers and/or rural health
clinics. Referrals will result in increased opportunities for free and low‐
cost, tobacco cessation, and chronic disease self‐management
workshops. The Rx for Health system will include training and support
for clinicians, changes to electronic medical records to track referrals,
and will build relationships with intervention participants to track the
success of referral practices. The evaluation team will administer an
innovative plan which will capture the extent to which the referral
system has an impact on patient’s health outcomes. Furthermore, all
patients who are identified as having uncontrolled hypertension will be
tracked from implementation up until the end of the evaluation period.
This evaluation strategy will allow us to report how many individuals
used the referral system, where attrition may occur throughout the
process, and how much of an impact the referral system has on health
behaviors and other health outcomes. A subset of patients who are
referred to lifestyle change programs will be closely monitored and will
be administered a survey which tracks motivation, perception,
behavior, and social support of patient’s hypertension management.
This intervention meets CDC's criteria for
innovative.
Explain This intervention is innovative because, to our
knowledge, there are no consensus
recommendations for program design and no
structured evaluations of the model in similar
populations. This evaluation will provide insight
on how well the referral program has reached
the population in consideration, as well as the
health outcome of the studied individuals.
No
Yes
Anticipated start date of intervention(month/year)4/1/2015
Anticipated end date of intervention(month/year)9/1/2017
Does intervention/strategy aim to reduce health
disparities?
The intervention focuses on a general population
only (typically jurisdiction wide)
The intervention aims to reduce health disparities by focusing on
both a general population(jurisdiction wide) and one or more
specific sub‐populations
Intervention Description
Please include a logic model for the intervention as an attachment when you submit your evaluation plan to CDC.
Tobacco
Nutrition
Physical Activity
Community and Clinical Linkages
Communication
Sunday, July 10, 2016 Page 18 of 56
Revised Exhibit A
Plan Name Prescription for Health
The intervention aims to reduce health disparities by focusing on
one or more specific sub‐populations
Sunday, July 10, 2016 Page 19 of 56
Revised Exhibit A
Plan Name Prescription for Health
Please list each of your evaluation questions. Evaluation questions should relate to the impact of an intervention/strategy on
specific health behaviors and/or health outcomes. Research questions are not appropriate. If this plan is to meet the actual
use assessment requirement, then at least one question should be related to actual use. In addition, all questions should
inform the evidence base and/or contribute to program improvement.
Evaluation Questions
Evaluation Question What indicators will be measured to
address this question?
Describe how this question will contribute to the evidence
base, program improvement, or an assessment of actual use.
This question will measure the effect of the prescription for
lifestyle modification on relevant behavioral changes.
Do patients
participating in the Rx
for Health program
demonstrate better
behavioral patterns
for chronic disease
self‐management
than non‐participants?
Weight in pounds
Body Mass Index
HbA1c level
Blood Pressure
Level of fasƟng low‐density
lipoprotein (LDL)
This question will contribute by measuring behavioral
patterns for smoking in individuals that participate in a
referral program.
What is the effect of
Rx for Health lifestyle
modification
programming on
patients’ smoking
behaviors compared
to those in non‐
participating clinics?
Number of individuals who quit
smoking
Number of smokers who have made a
quit attempt
This evaluation question will directly provide information on
the patients’ attitude, self‐efficacy, and social support
systems before and after the referral has been made.
Physical health outcomes as well as attitudinal changes that
may occur throughout the program will also be captured.
This question will also measure the impact of the referral
system on individuals who participate compared to those
who do not.
What is the effect of
Rx for Health lifestyle
modification
programming on
patients’ attitudes,
self‐efficacy, and
social support for
chronic disease self‐
management
compared to non‐
participating patients?
Proportion of individuals who make
behavioral changes to manage their
hypertension.
Proportion of individuals who make
attitudinal changes toward their
hypertension management.
Proportion of individuals who make
self‐efficacy changes toward their
hypertension management.
Proportion of individuals who make
social support changes to manage their
hypertension.
Sunday, July 10, 2016 Page 20 of 56
Revised Exhibit A
Plan Name Prescription for Health
This question will inform on a patient's smoking patterns
before and after the referral on behaviors, attitudues, self‐
efficacy, and social support. This question will also provide
insight on actual smoking cessation.
What is the effect of
Rx for Health lifestyle
modification
programming on
patients’ smoking
cessation behaviors,
attitudes, self‐
efficacy, and social
support compared to
non‐participating
patients?
Proportion of smokers who make
behavioral changes to their
management of hypertension.
Proportion of smokers who make
attitudinal changes to their
management of uncontrolled
hypertension.
Proportion of smokers who make self‐
efficacy changes to their management
of uncontrolled hypertension.
Proportion of smokers who make social
support changes to their management
of uncontrolled hypertension.
This question will contribute to the assessment of actual use
by tracking all individuals identified as having hypertension
and tracking which of those individuals are eventually
referred to a program. This is a preliminary step prior to the
health outcome evaluation of a subgroup of patients who
are enrolled in the referral program.
To what extent are
the referral programs
being used by
individuals with
uncontrolled
hypertension?
The proportion of individuals who are
actually using the referral program
compared to the total population
identified as having uncontrolled
hypertension.
The proportion of individuals who
complete all sessions of the referral
program compared to the number of
individuals who initially enrolled in the
program.
Sunday, July 10, 2016 Page 21 of 56
Revised Exhibit A
Plan Name Prescription for Health
Evaluation Design
Please describe the overall evaluation design, including the number and description of any comparison groups (if applicable)
and the timing and frequency of data collection (e.g., before and after implementation).
The proposed outcome evaluation will be a longitudinal design where all individuals identified as having uncontrolled
hypertension will be tracked for the duration of the program. A local clinic will identify and contact all patients who have
uncontrolled hypertension and attempt to recruit these individuals for the referral system. An evaluation of actual use will be
reported within several phases of the program. For example, of the patients who have uncontrolled hypertension, only a
certain proportion of individuals will successfully get in to see a physician or be referred. This is one example of the number
of individuals who actually use the services compared to those who do not. Furthermore, this evaluation is categorized as
innovative because we will track a subgroup of individuals who enroll in a lifestyle change program and compare them to
individuals who are delayed in their referral to the program. This will be accomplished by anticipating a staggered referral
process where a subset of individuals will have to wait in order to enroll in a lifestyle change program. This subset will be
interviewed two times prior to enrollment. We anticipate that in year‐2 we will sample and interview a total of 150
individuals whom are referred to the lifestyle change program. These individuals will be enrolled in the lifestyle change
program by two different cohorts, each with 75 individuals. All 150 individuals will be interviewed prior to enrollment. Cohort
A will receive a follow‐up interview after completion of a lifestyle change program and Cohort B will receive a follow‐up
interview prior to enrolling in the lifestyle change program. Cohort B will be used as a comparison group.
Sunday, July 10, 2016 Page 22 of 56
Revised Exhibit A
Plan Name Prescription for Health
Instruments
Please list each of your evaluation instruments/data sources. If you know the indicators you want to measure, but have not
yet selected the instruments, indicate "TBD" for the instrument. Please include available instruments as attachments when
you submit your evaluation plan to CDC.
Instrument/
Data Source
Reference Please describe any modifications
made to the original instrument
What key indicators are measured by this
instrument/data source?
Interview Survey Warren‐Findlow, Jan,
and Rachel B.
Seymour. "Prevalence
rates of hypertension
self‐care activities
among African
Americans." Journal
of the National
Medical Association
103.6 (2011): 503.
Han, Hae‐Ra, et al.
"Development and
validation of the
hypertension self‐care
profile: a practical
tool to measure
hypertension self‐
care." The Journal of
cardiovascular nursing
29.3 (2014): E11.
Douglas, Brenda M.,
and Elizabeth P.
Howard. "Predictors
of self‐management
behaviors in older
adults with
hypertension."
Advances in
preventive medicine
2015 (2015).
Several Questions from the H‐Scale
and the Hypertension Blood
Pressure Self‐Care Profile were
adapted for the interview survey
used throughout this evaluation. The
measures included have been peer‐
reviewed in academic journals and
demonstrate a high level of
reliability and validity for measuring
behaviors and other related factors
to the management of hypertension.
The items selected for our interview
survey demonstrated the highest
level of factor loading when a factor
analysis was administered. Please
view the references provided above
for an extensive review of the two
scales. Questions of demography
were supplemental to the survey.
Proportion of individuals who make
behavioral changes to manage their
hypertension.
Proportion of smokers who make
attitudinal changes to their management
of uncontrolled hypertension.
Proportion of individuals who make
social support changes to manage their
hypertension.
Proportion of individuals who make self‐
efficacy changes toward their
hypertension management.
Number of individuals who quit smoking
Number of smokers who have made a
quit attempt
Instrument/
Data Source
Reference Please describe any modifications
made to the original instrument
What key indicators are measured by this
instrument/data source?
Clinica Patient
Tracking System
Tracking software called i2i Tracking
has been created to follow all
patients for the duration of the
evalution.
Weight in pounds
Body Mass Index
HbA1c level
Blood Pressure
Level of fasƟng low‐density lipoprotein
(LDL)
Sunday, July 10, 2016 Page 23 of 56
Revised Exhibit A
Plan Name Prescription for Health
Sampling Plan
Interview SurveyInstrument Name
Age
Homeless/transient
Immigrants/Non‐native English speakers
LGBTQ
Low SES/income
People w/disabilities (cognitive or Physical)
People w/mental illness/substance abuse conditions
Race Ethnicity
Uninsured/underinsured
Other disparate subpopulation
Gender
Geography (urban, rural or frontier)
DescriptionSub‐population
Are you trying to represent any specific subpopulations in your sample? If yes, please complete this table by checking the
subpopulation included in your sample, indicating the desired sample size per group, and describing in the space provided.
How will you recruit and/or select participants to respond to this instruments?
All patients identified as having uncontrolled hypertension will have the opportunity to participate in a lifestyle change
program. Of those patients identified as having uncontrolled hypertension, a subset of patients will be randomly selected to
Sampling Plan
Intended Sample Size
This sampling approach allows us to evaluate the impact of the referral programs by comparing individuals who have been
referred to those who have not yet participated in the lifestyle change programs. Eventually, the delayed (comparison)
group will have the opportunity to participate in the lifestyle change program. Assignment to the immediate or delayed
cohort will be random.
Please provide your reasoning and/or justification for the sampling appoach. Address all levels of the sampling plan.
A limitation in this design is that patients who are sampled may represent a bias group who are willing to participate in the
health care system. We do not know the reasons for some individuals who are identified as having uncontrolled
hypertension for not participating.
Yes No (why not?)Not applicable
Describe the limitations of the sampling plan.
Did you conduct a power analysis?
NoYesIf yes, is your intended sample size sufficiently powered? Please explain.
Yes, if the intended sample size is obtained we will be jusƟfied in using inferenƟal staƟsƟcs.
# Level
Number of
Units
Intended
Sample Size Sampling Approach
1 Patient 2500 300 convenience
A random sample of patients will be generated from a subset of patients who qualify to be referred to a lifestyle change
program. Our appoach is to sample cohorts of patients that will be referred at different times to the lifestyle change
program. The go
Sunday, July 10, 2016 Page 24 of 56
Revised Exhibit A
Plan Name Prescription for Health
Will you use participation incentives to promote response rate to the instrument?
take the interview survey. Patient navigators will administer the intervew survey twice to each patient. The evaluation team
and the patient navigators will work closely to ensure that patients are in the correct cohort.
Yes (please describe)Each participant has the opportunity of receiving a $25 gift card with the completion of the
second survey. In order to receive the incentive, the patient must have completed the No
Sunday, July 10, 2016 Page 25 of 56
Revised Exhibit A
Plan Name Prescription for Health
Clinica Patient Tracking SystemInstrument Name
Age
Homeless/transient
Immigrants/Non‐native English speakers
LGBTQ
Low SES/income
People w/disabilities (cognitive or Physical)
People w/mental illness/substance abuse conditions
Race Ethnicity
Uninsured/underinsured
Other disparate subpopulation
Gender
Geography (urban, rural or frontier)
DescriptionSub‐population
Are you trying to represent any specific subpopulations in your sample? If yes, please complete this table by checking the
subpopulation included in your sample, indicating the desired sample size per group, and describing in the space provided.
How will you recruit and/or select participants to respond to this instruments?
Will you use participation incentives to promote response rate to the instrument?
All patients identified as having uncontrolled hypertension will be contacted for this program. Patient Navigators will make
several attempts at enrolling all individuals.
Yes (please describe)
No
Sampling Plan
Intended Sample Size
A universal sampling approach will be implemented in order to capture the extent to which the intervention successfully
manages the population that is identified as having uncontrolled hypertension. The evaluation team understands that not all
individuals will participate in the program. However, a universal sampling approach will allow us to capture the proportion
of attrition throughout the implementation process.
Please provide your reasoning and/or justification for the sampling appoach. Address all levels of the sampling plan.
There are no foreseable limitations at this time.
Yes No (why not?)Not applicable
Describe the limitations of the sampling plan.
Did you conduct a power analysis?
NoYesIf yes, is your intended sample size sufficiently powered? Please explain.
# Level
Number of
Units
Intended
Sample Size Sampling Approach
1 1 2500 2500 universal
No sampling approach occur at this level. All individuals who are identified as having uncontrolled hypertension will be
tracked throughout program implementation.
Sunday, July 10, 2016 Page 26 of 56
Revised Exhibit A
Plan Name Prescription for Health
Data Collection Plan
Instrument Name Interview Survey
Please describe in detail the data collection protocol for
this instrument.
Behavioral health outcomes will be collected from electronic
medical records and all other types of data that are related to
the management of hypertension will be collected from the
interview survey. Healthcare professionals (e.g. physicians,
nurses, and patient navigators) will directly input data into the
electronic medical records system whenever appropriate.
Patient navigators will be trained on how to administer and
collect data from the interview survey instrument. Patient
navigators will assist patients in filling out the survey
instrument which will be completed either at the clinic or over
the phone. Each interview will take approximately 30 to 40
minutes. The patient navigator will administer the survey twice
to each patient and at the second interview will provide the
participant with a gift card for participation. CVHPI will work
closely with the patient navigators, Fresno Department of
Public Health, and the life‐style change referral group to ensure
data is securely and accurately stored. Patient navigators will
share the survey data and the medical records data with CVHPI
for evaluation.
Who will administer this instrument/collect the data?Trained research assistants will administer the instrument.
How will you train data collectors to ensure data are
collected accurately and reliably?
Patient Navigators will be trained prior to administering the
informed consent and survey by a mock exercise to ensure
accurate data collection. A full review of all the items on the
survey will be thoroughly discussed by the evaluation team and
the Patient Navigators to ensure that the navigator can explain
the survey content to a patient.
Observation
Survey
Intercept survey
Interview
Records review
Please select the data collection method.
1 time
2 times
3 or more times
timing is continuous or ongoing
How many times will you administer this instrument?
Please describe the timing for when you will collect data.The interview survey will be administered twice. The survey will
be administered once prior to enrollment in a lifestyle change
program and a second time after completion of the program. A
small subgroup of patients will take the survey twice prior to
enrollment in a lifestyle change program in order to have a
comparison group. There will be approximately 3 to 6 months
in between each survey.
Sunday, July 10, 2016 Page 27 of 56
Revised Exhibit A
Plan Name Prescription for Health
Will you collect data from the same individuals over time
(longitudinal) or from independent samples at each time
point (cross‐sectional)?
Longitudinal Cross‐sectional
Instrument Name Clinica Patient Tracking System
Please describe in detail the data collection protocol for
this instrument.
The electronic software used by the clinic is called i2i Tracking.
Indicators have been manually entered to reflect behavioral
indicators for hypertension management.
Who will administer this instrument/collect the data?Data is automatically updated by health care professionals and
patient navigators.
How will you train data collectors to ensure data are
collected accurately and reliably?
Health care professionals and Patient Navigators have been
trained to upload data.
Will you collect data from the same individuals over time
(longitudinal) or from independent samples at each time
point (cross‐sectional)?
Longitudinal Cross‐sectional
Observation
Survey
Intercept survey
Interview
Records review
Please select the data collection method.
1 time
2 times
3 or more times
timing is continuous or ongoing
How many times will you administer this instrument?
Please describe the timing for when you will collect data.Data will be collected at sevaral points throughout
implementation of the program. All patients who are identified
as having uncontrolled hypertension will have data collected
from the electronic tracking system. Additional data will be
collected on individuals who come in to see a physician, at this
point patients who refuse will be included in evaluation reports
but will not be tracked. Data will be continuously tracked for
individuals throughout program implementation so that we can
evaluate attrition as well as the behavioral advances that
participating patients make.
Sunday, July 10, 2016 Page 28 of 56
Revised Exhibit A
Plan Name Prescription for Health
Complete a data analysis plan for each question.
Data Analysis Plan
Do patients participating in the Rx for Health program demonstrate better
behavioral patterns for chronic disease self‐management than non‐
participants?
Evaluation Question
What indicators will be examined?
Body Mass Index
HbA1c level
Blood Pressure
Level of fasƟng low‐density lipoprotein (LDL)
Weight in pounds
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
Descriptive analysis will be conducted by demographic characteristics as
well as health categories. This indicator will be tracked over a 6 month
period to determine the extent to which lifestyle change referrals impact
physical health.
N/A
What procedures will you conduct to test
your assumptions?
N/A
What types of variables will be examined?
What descriptive analyses will you perform?
What is the effect of Rx for Health lifestyle modification programming on
patients’ smoking behaviors compared to those in non‐participating clinics?
Evaluation Question
What indicators will be examined?
Number of smokers who have made a quit aƩempt
Number of individuals who quit smoking
Sunday, July 10, 2016 Page 29 of 56
Revised Exhibit A
Plan Name Prescription for Health
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
Descriptive analysis will be conducted by demographic characteristics as
well as health categories. This indicator will be tracked over a 6 month
period to determine the effect of the program.
Repeated measures will be used to conduct inferential analysis for the
entire population.
What procedures will you conduct to test
your assumptions?
Tests of tool validity and reliability will be conducted prior to any analysis.
What types of variables will be examined?
What descriptive analyses will you perform?
What is the effect of Rx for Health lifestyle modification programming on
patients’ attitudes, self‐efficacy, and social support for chronic disease self‐
management compared to non‐participating patients?
Evaluation Question
What indicators will be examined?
Proportion of individuals who make social support changes to manage their
hypertension.
Proportion of individuals who make behavioral changes to manage their
hypertension.
Proportion of individuals who make attitudinal changes toward their
hypertension management.
Proportion of individuals who make self‐efficacy changes toward their
hypertension management.
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
Likert scales that measure attitude, behavioral, self‐efficacy and motivation
will be analyzed descriptively by acquiring frequencies, means, and
standard deviations of individuals within and across sites and time.
Paired samples t‐test will be used for analysis when appropriate. Generally,
these analyses will be used to measure attitudinal change over time.
What procedures will you conduct to test
your assumptions?
Tests of internal consistency (Cronbach's alpha) will be conducted.
What types of variables will be examined?
What descriptive analyses will you perform?
What is the effect of Rx for Health lifestyle modification programming on
patients’ smoking cessation behaviors, attitudes, self‐efficacy, and social
support compared to non‐participating patients?
Evaluation Question
What indicators will be examined?
Proportion of smokers who make social support changes to their
management of uncontrolled hypertension.
Proportion of smokers who make behavioral changes to their management
of hypertension.
Proportion of smokers who make attitudinal changes to their management
of uncontrolled hypertension.
Proportion of smokers who make self‐efficacy changes to their management
of uncontrolled hypertension.
Sunday, July 10, 2016 Page 30 of 56
Revised Exhibit A
Plan Name Prescription for Health
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
Likert scales that measure attitude, behavior, motivation, self‐efficacy and
social support will analyzed descriptively by acquiring frequencies, means,
and standard deviations of individuals within and across sites and time.
Paired samples t‐test will be used for analysis when appropriate. Generally,
these analyses will be used to measure smoking attitudinal change over
time.
What procedures will you conduct to test
your assumptions?
Tests of internal consistency (Cronbach's alpha) will be conducted.
What types of variables will be examined?
What descriptive analyses will you perform?
To what extent are the referral programs being used by individuals with
uncontrolled hypertension?
Evaluation Question
What indicators will be examined?
The proportion of individuals who complete all sessions of the referral
program compared to the number of individuals who initially enrolled in the
program.
The proportion of individuals who are actually using the referral program
compared to the total population identified as having uncontrolled
hypertension.
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
These data will be analyzed descriptively to obtain frequencies and
percentage of individuals that participate in the lifestyle change program.
Inferential statistics are not applicable in this case.
What procedures will you conduct to test
your assumptions?
Test of assumptions are not applicable in this case.
What types of variables will be examined?
What descriptive analyses will you perform?
Sunday, July 10, 2016 Page 31 of 56
Revised Exhibit A
Plan Name Prescription for Health
Dissemination Plan
Board county members, Community members, CDC and peer‐reviewed journal.
Due to the innovative approach of this evaluation, it is a priority to disseminate
the valuable information gathered from this assessment. We intend to develop
preliminary analysis and a report describing the initial findings of the screening
tool as well as a final analysis and final report that extend in detail the findings
and implications of this evaluation. All descriptive and inferential findings will
be written and shared primarily with the community as well as conferences, a
variety of academic settings, and potentially through a peer‐reviewed journal.
CVHPI will work in conjunction with FCDPH for all dissemination purposes.
List all audiences for the evaluation findings
How will you disseminate the findings from
this evaluation?
Do you plan to develop a peer ‐ reviewed
manuscript based on this evaluation?
Yes
No
Sunday, July 10, 2016 Page 32 of 56
Revised Exhibit A
Plan Name Prescription for Health
For each milestone, please indicate the current status and anticipated or actual dates of initiation and completion. Also
indicate the specific activities that must be completed to achieve each milestone.
Evaluation Work Plan
Finalize evaluation plan
Evaluation Milestone Milestone Status Milestone Init Date
4/1/2015
Milestone Completion Dat
9/30/2015Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Obtain IRB approval / exemption
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect baseline data
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze baseline data
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 33 of 56
Revised Exhibit A
Plan Name Prescription for Health
Disseminate baseline data
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 34 of 56
Revised Exhibit A
Plan Name Prescription for Health
Collect followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 35 of 56
Revised Exhibit A
Plan Name Prescription for Health
Analyze followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 36 of 56
Revised Exhibit A
Plan Name Storefront Advertising
This plan measures actual use
This is a required outcome evaluation of an innovative intervention
This is a voluntary evaluation
What is the purpose of this plan?
Is this evaluation/assessment focused on a single intervention or a broader strategy (group of interventions
aiming to achieve similar outcomes)?
Single Intervention
Strategy (group of interventions)
Overview
John A. Capitman, PhD
Executive Director, Central Valley Health Policy Institute
California State University, Fresno
(559) 228‐2157
jcapitman@csufresno.edu
List any topics you would like to see addressed through evaluation TA, webinars, collaborative calls or other training
opportunities.
Nam
Title
Affiliation
Phone
Emai
Who is the primary point of contact for this evaluation plan?
Sunday, July 10, 2016 Page 37 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Storefront and Outdoor AdvertisingIntervention/strategy name
Risk factor(s)/focus areas
Description The FCDPH will identify target cities using the Healthy Stores for a
Healthy Community Workgroup assessment in Fresno County. FCDPH
will educate and inform community members, retailers, and decision‐
makers and provide technical assistance in the targeted communities to
reduce storefront and outdoor advertising. An estimated 623,721
people will be reached in a minimum of five cities including Kingsburg,
Fresno, Parlier, Firebaugh, and Clovis. The evaluation will target
selected stores within the ordinance jurisdiction and measure
storefront adherence to the law and perception of advertising. The
Evaluation Team has developed a plan to randomly select stores within
the targeted communities and will measure compliance of storefront
advertising. The Evaluation Team will also conduct intercept surveys on
consumers who have made a purchase.
This intervention meets CDC's criteria for
innovative.
Explain
No
Yes
Anticipated start date of intervention(month/year)8/15/2014
Anticipated end date of intervention(month/year)9/29/2017
Does intervention/strategy aim to reduce health
disparities?
The intervention focuses on a general population
only (typically jurisdiction wide)
The intervention aims to reduce health disparities by focusing on
both a general population(jurisdiction wide) and one or more
specific sub‐populations
The intervention aims to reduce health disparities by focusing on
one or more specific sub‐populations
Intervention Description
Please include a logic model for the intervention as an attachment when you submit your evaluation plan to CDC.
Tobacco
Nutrition
Physical Activity
Community and Clinical Linkages
Communication
Sunday, July 10, 2016 Page 38 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Please list each of your evaluation questions. Evaluation questions should relate to the impact of an intervention/strategy on
specific health behaviors and/or health outcomes. Research questions are not appropriate. If this plan is to meet the actual
use assessment requirement, then at least one question should be related to actual use. In addition, all questions should
inform the evidence base and/or contribute to program improvement.
Evaluation Questions
Evaluation Question What indicators will be measured to
address this question?
Describe how this question will contribute to the evidence
base, program improvement, or an assessment of actual use.
We will assess the Department’s ability to reduce storefront
and outdoor advertising. This question will measure the
extent to which stores adhere to adopted policy in their city.
We will meaure the amount of advertising before and after
the policy is passed.
In communities that
have made policy
changes related
storefront advertising,
has the level of
storefront and
outdoor advertising
been reduced
compared to pre‐
policy baseline?
The proportion of storefront window
advertisements
This question will measure levels of alcohol, tobacco and
sugary drink purchases. The amount of alcohol, tobacco and
sugary drinks purchased will be estimated from a random
sample of consumers who will be surveyed after making a
purchase. This question will contribute to the evidence for
the association between storefront advertising and youth
purchasing alcohol, tobacco and sugary drinks.
In communities that
have adopted new
storefront advertising
policies, to what
extent has the
purchase of alcohol
and tobacco
decreased?
The number of individuals who buy
tobacco products, alcoholic beverages,
and/or sugary drinks
This question will measure if the policy changes the
community's attitude towards storefront appeal. This
question will inform is shoppers change their perception of
stores due to the amount of storefront advertising.
In the communities
that have adopted
new policies and have
reduced the total
amount of storefront
advertising, to what
extent do shopper’s
attitudes change on
storefront appeal?
Number of participants who find the
storefront appealing
Sunday, July 10, 2016 Page 39 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Evaluation Design
Please describe the overall evaluation design, including the number and description of any comparison groups (if applicable)
and the timing and frequency of data collection (e.g., before and after implementation).
The Central Valley Health Policy Institute (CVHPI) will randomly select five stores per zip code within the within each target
city. Zip codes will be selected using previous research that has been conducted in the region on tobacco use and on the
population of the jurisdiction. In areas of high population density, more stores will be sampled. These stores will be observed
for baseline and follow‐up data after the intervention has been implemented. CVHPI will collect baseline data prior to the
policy being passed, and then collect follow‐up data 3 to 6 months after the policy has been passed. Each observation will
include the implementation of an observational tool and an intercept survey of consumers. The observational tool will cover
the measurement of the storefront advertising and the intercept surveys will capture use and public perception of storefront
advertising. On average, ten intercept surveys will be collected per store with the cities with higher population being over
sampled. A grand total of 500 participants are expected to be collected over the three‐year period in at least four different
cities. Data will be collected using intercept survey methods. Individuals older than the age of 18 will be intercepted by a
research assistant with survey. Independent samples will be collected at each observation.
Sunday, July 10, 2016 Page 40 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Instruments
Please list each of your evaluation instruments/data sources. If you know the indicators you want to measure, but have not
yet selected the instruments, indicate "TBD" for the instrument. Please include available instruments as attachments when
you submit your evaluation plan to CDC.
Instrument/
Data Source
Reference Please describe any modifications
made to the original instrument
What key indicators are measured by this
instrument/data source?
Intercept survey Stanford PrevenƟon
Research Center
California Tobacco
Control Progrm (2013)
Only two questions from the original
instrument will be uƟlized: 7 and
N17. AddiƟonal quesƟons will inclu
de: •Do you live in this community?
•Which category best describes
your race?
•Which category best describes
your gender?
•Have you smoked any cigareƩes
in the last 30 days?
•Do you shop here regularly?
•Did you purchase anything that is
being advertised on storefront or
outdoor advertising?
•Do you think youth are influenced
by storefront advertising at this
store?
•Do you find this storefront
appealing?
•Did you purchase alcohol?
•Did you purchase cigareƩes?
•Did you purchase fruits or
vegetables ?
•Did you purchase soda, Gatorade,
or an energy drink?
The number of individuals who buy
tobacco products, alcoholic beverages,
and/or sugary drinks
Number of participants who find the
storefront appealing
Instrument/
Data Source
Reference Please describe any modifications
made to the original instrument
What key indicators are measured by this
instrument/data source?
Instrument/
Data Source
Reference Please describe any modifications
made to the original instrument
What key indicators are measured by this
instrument/data source?
Observational Tool Window Signage Fact
Sheet, Los Angeles
County Public Health
Department
A photograph will be taken of the
storefront and the proportion of
storefront signage will be
determined from the photograph.
The proportion of storefront window
advertisements
Sunday, July 10, 2016 Page 41 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Sampling Plan
Intercept surveyInstrument Name
DescriptionSub‐population
Are you trying to represent any specific subpopulations in your sample? If yes, please complete this table by checking the
subpopulation included in your sample, indicating the desired sample size per group, and describing in the space provided.
Sampling Plan
Intended Sample Size
The Central Valley Health Policy InsƟtute will randomly sampl stores within the ordinance jurisdicƟon. We believe that a
random sample of stores will accurately reflect the impact of the intervention. Stores located in zip codes where there is a
high population density will be over sampled. In rural communities, fewer stores will be sampled. At a person‐level, we will
gather a convenience sample of consumers via intercept surveys. This will allow the evaluation team to accurately measure
purchases, attitudes, and behaviors of individuals.
Please provide your reasoning and/or justification for the sampling appoach. Address all levels of the sampling plan.
The sampling of stores may create bias observaƟons that may not reflect the community as a whole. This might be due to
the limited number of stores we are able to evaluate. Another limitation is that we are only allowed to gather informed
consent from individuals older than 18 years of age, some of the advertising for sugary‐drinks are geared toward a younger
demographic.
Yes No (why not?)Not applicable
Describe the limitations of the sampling plan.
Did you conduct a power analysis?
This is a voluntary evaluaƟon.
NoYesIf yes, is your intended sample size sufficiently powered? Please explain.
# Level
Number of
Units
Intended
Sample Size Sampling Approach
1Store 30 30 convenience
Stores within the ordinance jurisdiction will be randomly sampled.
2 Customers 528090 500 convenience
Each observation will include the collection of 25 participants so that each store sampled will have a total of 50 participants
to compare pre and post intervention. A grand total of 500 participants are expected to be collected over the three‐year
period
Sunday, July 10, 2016 Page 42 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Age
Homeless/transient
Immigrants/Non‐native English speakers
LGBTQ
Low SES/income
People w/disabilities (cognitive or Physical)
People w/mental illness/substance abuse conditions
Race Ethnicity
Uninsured/underinsured
Other disparate subpopulation
Gender
Geography (urban, rural or frontier)
How will you recruit and/or select participants to respond to this instruments?
Will you use participation incentives to promote response rate to the instrument?
Participant recruitment will occur at local community events, swap meets, etc. within the targeted communties.
Yes (please describe)
No
Sunday, July 10, 2016 Page 43 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Instrument Name
Age
Homeless/transient
Immigrants/Non‐native English speakers
LGBTQ
Low SES/income
People w/disabilities (cognitive or Physical)
People w/mental illness/substance abuse conditions
Race Ethnicity
Uninsured/underinsured
Other disparate subpopulation
Gender
Geography (urban, rural or frontier)
DescriptionSub‐population
Are you trying to represent any specific subpopulations in your sample? If yes, please complete this table by checking the
subpopulation included in your sample, indicating the desired sample size per group, and describing in the space provided.
How will you recruit and/or select participants to respond to this instruments?
Will you use participation incentives to promote response rate to the instrument?
Yes (please describe)
No
Sampling Plan
Intended Sample Size
Please provide your reasoning and/or justification for the sampling appoach. Address all levels of the sampling plan.
Yes No (why not?)Not applicable
Describe the limitations of the sampling plan.
Did you conduct a power analysis?
NoYesIf yes, is your intended sample size sufficiently powered? Please explain.
Sunday, July 10, 2016 Page 44 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Observational ToolInstrument Name
Age
Homeless/transient
Immigrants/Non‐native English speakers
LGBTQ
Low SES/income
People w/disabilities (cognitive or Physical)
People w/mental illness/substance abuse conditions
Race Ethnicity
Uninsured/underinsured
Other disparate subpopulation
Gender
Geography (urban, rural or frontier)
DescriptionSub‐population
Are you trying to represent any specific subpopulations in your sample? If yes, please complete this table by checking the
subpopulation included in your sample, indicating the desired sample size per group, and describing in the space provided.
How will you recruit and/or select participants to respond to this instruments?
Will you use participation incentives to promote response rate to the instrument?
The stores will be randomly selected for this portion of the evaluation.
Sampling Plan
Intended Sample Size
The stores will be randomly selected within each ordinance jurisdiction. The random selection will limit biases toward a
group of stores that may not represent the entire jurisdiction under the ordinance.
Please provide your reasoning and/or justification for the sampling appoach. Address all levels of the sampling plan.
A limited number of stores will be selected due to shortage in staffing. It would be ideal to randomly sample a large set of
stores throughout the County.
Yes No (why not?)Not applicable
Describe the limitations of the sampling plan.
Did you conduct a power analysis?
NoYesIf yes, is your intended sample size sufficiently powered? Please explain.
# Level
Number of
Units
Intended
Sample Size Sampling Approach
1Convenience Store 20 random
At least five stores will be randomly selected from within each ordinance jurisdiction. More stores will be selected for highly
populated cities. These stores will measured pre‐ and post‐intervention.
2
Sunday, July 10, 2016 Page 45 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Yes (please describe)
No
Sunday, July 10, 2016 Page 46 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Data Collection Plan
Instrument Name Intercept survey
Please describe in detail the data collection protocol for
this instrument.
Photographs of the store front will be taken pre and post
ordinance change. The observer will identify customers as they
walk out of the store. The observer will ask for informed
consent from all potential participants. If the customer
consents, the observer will proceed to administer the survey
instrument. The survey should take no longer than fifteen
minutes to administer. If necessary, surveys will be available in
Spanish and the observer will be trained on how to administer
these surveys.
Who will administer this instrument/collect the data?Trained observers/research assistants will administer the
instrument.
How will you train data collectors to ensure data are
collected accurately and reliably?
CVHPI will work in conjunction with the Fresno County Public
Health Department to train observers to administer the
instruments in the targeted communities. Observers will be
given a mock training to ensure accurate data collection.
Will you collect data from the same individuals over time
(longitudinal) or from independent samples at each time
point (cross‐sectional)?
Longitudinal Cross‐sectional
Observation
Survey
Intercept survey
Interview
Records review
Please select the data collection method.
1 time
2 times
3 or more times
timing is continuous or ongoing
How many times will you administer this instrument?
Please describe the timing for when you will collect data.The Central Valley Health Policy Institute (CVHPI) will randomly
select stores within the jurisdiction of the new ordinance.
These stores will be observed for baseline and follow‐up data
after the intervention has been implemented. The baseline
observation will occur prior to the implementation of the
ordinance and a follow‐up observation will occur after the
ordinance is being enforced. In each year of the grant, the goal
is to add more stores to be observed. The Evaluation Team will
maintain constant communication with partners to ensure that
baseline data is being collected in communities that are highly
considering to pass an ordinance which reduces storefront
advertising.
Instrument Name
Sunday, July 10, 2016 Page 47 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Please describe in detail the data collection protocol for
this instrument.
Who will administer this instrument/collect the data?
How will you train data collectors to ensure data are
collected accurately and reliably?
Will you collect data from the same individuals over time
(longitudinal) or from independent samples at each time
point (cross‐sectional)?
Longitudinal Cross‐sectional
Observation
Survey
Intercept survey
Interview
Records review
Please select the data collection method.
1 time
2 times
3 or more times
timing is continuous or ongoing
How many times will you administer this instrument?
Please describe the timing for when you will collect data.
Instrument Name Observational Tool
Please describe in detail the data collection protocol for
this instrument.
The observational tool will include taking a photograph of the
storefront and measuring the proportion of the storefront that
is dedicated to signage. The percent of signage will be
determined by dividing the signage area by the total
door/window storefront area. This proportion will be
compared pre‐ and post‐intervention to determine the effect
size of the storefront.
Who will administer this instrument/collect the data?A trained research assistant will take a photograph from a
specific distance from the storefront.
How will you train data collectors to ensure data are
collected accurately and reliably?
A mock trial will be conducted with the data collectors in order
to improve accuracy and reliablity of the observational tool.
Observation
Survey
Intercept survey
Interview
Records review
Please select the data collection method.
1 time
2 times
3 or more times
timing is continuous or ongoing
How many times will you administer this instrument?
Please describe the timing for when you will collect data.The observational tool will be administered twice for each store
site. The tool will be administered pre‐ and post‐intervention in
order to measure the effect of the ordinance.
Sunday, July 10, 2016 Page 48 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Will you collect data from the same individuals over time
(longitudinal) or from independent samples at each time
point (cross‐sectional)?
Longitudinal Cross‐sectional
Sunday, July 10, 2016 Page 49 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Complete a data analysis plan for each question.
Data Analysis Plan
In communities that have made policy changes related storefront
advertising, has the level of storefront and outdoor advertising been
reduced compared to pre‐policy baseline?
Evaluation Question
What indicators will be examined?
The proportion of storefront window advertisements
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
This value will be used to estimate the proportion of storefront advertising
at each observation time point. Pre and post photographs will be analyzed
to compare change and adherence to the new policy.
None.
What procedures will you conduct to test
your assumptions?
Interrater reliability will be calculated using a weighted kappa statistic.
What types of variables will be examined?
What descriptive analyses will you perform?
In communities that have adopted new storefront advertising policies, to
what extent has the purchase of alcohol and tobacco decreased?
Evaluation Question
What indicators will be examined?
The number of individuals who buy tobacco products, alcoholic beverages,
and/or sugary drinks
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
Frequencies and percentages will be calculated for analysis. These data will
provide information for comparison of data prior to the ordinance and after
the ordinance has been passed.
These values will be compared across stores, cities, and observation times.
Frequencies, means, and standard deviations will be used to compare
proportional differences across groups. This analysis will help us infer actual
use of stores in a community.
What procedures will you conduct to test
your assumptions?
Once all data has been collected, pre‐intervention observations will be
compared to post‐intervention groups via a paired samples t‐test. This
inferential statistic will examine if the intervention was significantly
impactful on the population.
What types of variables will be examined?
What descriptive analyses will you perform?
In the communities that have adopted new policies and have reduced the
total amount of storefront advertising, to what extent do shopper’s
attitudes change on storefront appeal?
Evaluation Question
What indicators will be examined?
Number of participants who find the storefront appealing
Sunday, July 10, 2016 Page 50 of 56
Revised Exhibit A
Plan Name Storefront Advertising
OrdinalNominal Interval Ratio
What inferential analyses will you conduct to
answer your evaluation question?
Frequencies and proportions of answers will be analyzed descriptively.
Pre and post intervention groups will also be compared via a paired
samples t‐test to measure the impact of storefront advertisement on
attitudes/behaviors.
What procedures will you conduct to test
your assumptions?
Pre and post intervention groups will also be compared via a paired
samples t‐test to measure the impact of storefront advertisement on
attitudes/behaviors.
What types of variables will be examined?
What descriptive analyses will you perform?
Sunday, July 10, 2016 Page 51 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Dissemination Plan
City Counvil memebers, County board members, Fresno County Health
Improvement Partnership members, community members, CDC.
All findings will be written and shared primarily with the community as well as
conferences, flyers, school site newsletters,, social media platforms, a variety of
academic settings, and potentially through a peer‐reviewed journal such as
Nutrition Education and Behavior, Health Education and Behavior, The Journal
of Child Nutrition and Management, and Health Psychology. The findings
generated by this actual use assessment may be utilized by stakeholders in
creating a platform to present evidence to community leaders and policy
makers for positive changes to the current storefront advertisement practices.
CVHPI will work in conjunction with FCDPH for all dissemination purposes.
List all audiences for the evaluation findings
How will you disseminate the findings from
this evaluation?
Do you plan to develop a peer ‐ reviewed
manuscript based on this evaluation?
Yes
No
Sunday, July 10, 2016 Page 52 of 56
Revised Exhibit A
Plan Name Storefront Advertising
For each milestone, please indicate the current status and anticipated or actual dates of initiation and completion. Also
indicate the specific activities that must be completed to achieve each milestone.
Evaluation Work Plan
Finalize evaluation plan
Evaluation Milestone Milestone Status Milestone Init Date
4/1/2015
Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Obtain IRB approval / exemption
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect baseline data
Evaluation Milestone Milestone Status Milestone Init Date
5/1/2013
Milestone Completion Dat
9/30/2013Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze baseline data
Evaluation Milestone Milestone Status Milestone Init Date
10/1/2013
Milestone Completion Dat
12/31/2013Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 53 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Disseminate baseline data
Evaluation Milestone Milestone Status Milestone Init Date
1/1/2014
Milestone Completion Dat
12/31/2014Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (1)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 54 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Collect followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Analyze followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (2)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Collect followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 55 of 56
Revised Exhibit A
Plan Name Storefront Advertising
Analyze followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Disseminate followup data (3)
Evaluation Milestone Milestone Status Milestone Init Date Milestone Completion Dat
Complete
In Progress
Delayed
Not yet started
N/A
Check completed Activity Activity Init Date Activity Completion Date Lead staff
Activities
Sunday, July 10, 2016 Page 56 of 56
Revised Exhibit A
Revised Exhibit B-1
Page 1 of 1
A. Salaries and Wages
Last Name Init. Annual
Salary % Time Program
Salary % Time Program
Salary
Total
Request
FACULTY
Capitman J $139,800 18%$25,224 1%$1,631 $26,855
Subtotal Faculty Salaries $26,855
STAFF
Bengiamin M $90,000 40%$35,775 15%$13,500 $49,275
Lessard L $54,204 8%$4,300 0%$0 $4,300
Alcala/Constantino E $41,600 23%$9,360 39%$16,380 $25,740
Garcia M $34,000 23%$7,650 0%$0 $7,650
Silva Y $32,000 22%$6,960 31%$9,900 $16,860
Cortez J $32,000 27%$8,640 26%$8,250 $16,890
Interns $0 0%$0 0%$0 $0
Subtotal Staff Salaries $120,715
$147,570
Rate Rate
Capitman J Principal Investigator 42%$10,594 42%$685 $11,279
Bengiman M Research Director 30%$10,733 28%$3,780 $14,513
Lessard L Project Coord.32%$1,376 0%$0 $1,376
Alcala/Constantino E Data Analyst 34%$3,182 30%$4,914 $8,096
Garcia M Research Assistant 35%$2,678 0%$0 $2,678
Silva Y Research Assistant 35%$2,436 10%$990 $3,426
Cortez J Research Assistant 10%$864 10%$825 $1,689
Interns Research Assistants 0%$0 0%$0 $0
$43,056
$190,626
$0 $0 $0
$0 $0 $0
$750 $1,000 $1,750
$750 $1,000 $1,750
$5,000 $0 $5,000
$5,000 $0 $5,000
Description
Meeting and office
supplies and
communication
$5,238 $2,313 $7,551
Office space and meeting
room rental $7,200 $6,000 $13,200
$12,438 $8,313 $20,751
$147,959 $70,168 $218,127
$142,959 $70,168 $213,127
Rate:19.0%of MTDC $27,162 $13,332 $40,494
$175,121 $83,500 $258,621
TOTAL EQUIPMENT
J. Indirect Costs
Modified Total Direct Co
Data Analyst
Research Assistant
Research Assistant
Research Assistant
Research Assistants
TOTAL OTHER
Equipment or Facility Rental/User
Fees $600 x 12 months
Materials and Supplies
F. Other Direct Support
TOTAL PARTICIPANT/TRAINEE SUPPORT
TOTAL TRAVEL
Research Director
Project Coord.
Year 1
7/14/15- 9/29/16
Year 2
9/30/16-9/29/17
Position
Principal Investigator
Subtotal ALL Salaries and Wages
$11,194
$60,855
$31,862
$129,771
Subtotal Fringe Benefits
TOTAL SALARY AND FRINGE BENEFITS
B. Fringe Benefits
$25,224 $1,631
$48,030
$49,661
$72,685
$97,909
C. Equipment
I. Total Direct Costs
K. Total Proposed Costs
Incentives
Local mileage at current IRS rates
E. Participant/Trainee Support
D. Travel
Calculation